Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypoglycemia01:26

Hypoglycemia

21
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
21
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

5.3K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
5.3K
Hyperglycemia01:29

Hyperglycemia

23
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
23
Hyperosmolar Hyperglycemic State01:21

Hyperosmolar Hyperglycemic State

11
Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
11
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

14
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
14

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel oral agents in anti-obesity pharmacotherapy: A narrative review.

Diabetes, obesity & metabolism·2025
Same author

Tight Blood-Glucose Control without Early Parenteral Nutrition in the ICU.

The New England journal of medicine·2023
Same author

Glycemic management and clinical outcomes in underserved minority kidney transplant recipients with type 2 and posttransplantation diabetes: A single-center retrospective study.

Diabetes research and clinical practice·2020
Same author

A DRAMATIC RESPONSE TO DENOSUMAB: PROTRACTED HYPOCALCEMIA RELATED TO HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE 1-ASSOCIATED ADULT T-CELL LEUKEMIA/LYMPHOMA.

AACE clinical case reports·2020
Same author

BASELINE TSH LEVEL IS ASSOCIATED WITH RISK OF ANTI-PD-1-INDUCED THYROID DYSFUNCTION.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2019
Same author

Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy.

Annals of internal medicine·2018

Related Experiment Video

Updated: Apr 24, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.7K

Understanding hypoglycemia in hospitalized patients.

Raphael D Hulkower1, Rena M Pollack2, Joel Zonszein2

  • 1Department of Medicine, Jacobi Medical Center, NY, USA.

Diabetes Management (London, England)
|September 9, 2014
PubMed
Summary

Controlling blood glucose in hospitalized patients is crucial. Recent studies suggest inpatient hypoglycemia may be a biomarker of disease, not a direct cause of death, shifting focus to patient-specific care.

More Related Videos

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
07:35

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Published on: January 26, 2024

2.1K
Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing
10:32

Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing

Published on: January 11, 2013

16.1K

Related Experiment Videos

Last Updated: Apr 24, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.7K
Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
07:35

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Published on: January 26, 2024

2.1K
Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing
10:32

Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing

Published on: January 11, 2013

16.1K

Area of Science:

  • Internal Medicine
  • Endocrinology
  • Hospital Patient Management

Background:

  • Blood glucose control in hospitalized patients is vital, as both hyperglycemia and hypoglycemia correlate with adverse outcomes.
  • Concerns regarding iatrogenic hypoglycemia have influenced clinical guidelines towards more conservative glycemic targets.
  • Patient-specific management strategies are increasingly recommended, differentiating care for stable versus critically ill individuals.

Purpose of the Study:

  • To evaluate the association of inpatient hypoglycemia with mortality.
  • To differentiate the mortality impact of spontaneous versus iatrogenic hypoglycemia.
  • To inform clinical practice and guidelines regarding inpatient glycemic control.

Main Methods:

  • Review of recent studies examining inpatient hypoglycemia and mortality rates.
  • Analysis of the relationship between hypoglycemia type (spontaneous vs. iatrogenic) and patient outcomes.
  • Assessment of current clinical guidelines for glycemic control in hospitalized patients.

Main Results:

  • Recent studies indicate a higher mortality rate associated with spontaneous hypoglycemia compared to iatrogenic hypoglycemia.
  • The findings challenge the perception of hypoglycemia as a primary cause of death in hospitalized patients.
  • Inpatient hypoglycemia may serve as an indicator of underlying disease severity.

Conclusions:

  • While avoiding hypoglycemia remains essential, its role in mortality may be that of a biomarker rather than a direct cause.
  • Clinical guidelines should continue to emphasize patient-specific glycemic management.
  • Further research may refine the understanding of hypoglycemia's impact on patient outcomes in hospital settings.